Florian Krismer
Florian Krismer
Department of Neurology, Medical University Innsbruck
Verified email at - Homepage
Cited by
Cited by
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ...
Movement Disorders 32 (6), 853-864, 2017
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ...
Movement Disorders 32 (6), 853-864, 2017
Multiple system atrophy.
A Fanciulli, I Stankovic, F Krismer, K Seppi, J Levin, GK Wenning
International review of neurobiology 149, 137-192, 2019
Multiple system atrophy.
GK Wenning, F Krismer
Handbook of clinical neurology 117, 229-241, 2012
The natural history of multiple system atrophy: a prospective European cohort study
GK Wenning, F Geser, F Krismer, K Seppi, S Duerr, S Boesch, ...
The Lancet Neurology 12 (3), 264-274, 2013
Magnetic resonance imaging for the diagnosis of ParkinsonĘs disease
B Heim, F Krismer, R De Marzi, K Seppi
Journal of Neural Transmission, 1-50, 2017
Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group
I Stankovic, F Krismer, A Jesic, A Antonini, T Benke, RG Brown, DJ Burn, ...
Movement Disorders 29 (7), 857-867, 2014
The movement disorder society criteria for the diagnosis of multiple system atrophy
GK Wenning, I Stankovic, L Vignatelli, A Fanciulli, G Calandra‐Buonaura, ...
Movement Disorders 37 (6), 1131-1148, 2022
Multiple system atrophy: insights into a rare and debilitating movement disorder
F Krismer, GK Wenning
Nature Reviews Neurology 13 (4), 232-243, 2017
Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management
M Metzler, S Duerr, R Granata, F Krismer, D Robertson, GK Wenning
Journal of neurology 260 (9), 2212-2219, 2013
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
G Respondek, C Kurz, T Arzberger, Y Compta, E Englund, LW Ferguson, ...
Movement Disorders 32 (7), 995-1005, 2017
Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease
P Mahlknecht, F Krismer, W Poewe, K Seppi
Movement Disorders 32 (4), 619-623, 2017
Dorsolateral nigral hyperintensity on 3.0 T susceptibility‐weighted imaging in neurodegenerative Parkinsonism
E Reiter, C Mueller, B Pinter, F Krismer, C Scherfler, R Esterhammer, ...
Movement Disorders 30 (8), 1068-1076, 2015
Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism
F Krismer, B Pinter, C Mueller, P Mahlknecht, M Nocker, E Reiter, ...
Parkinsonism & related disorders 35, 36-41, 2017
A critique of the second consensus criteria for multiple system atrophy
I Stankovic, N Quinn, L Vignatelli, A Antonini, D Berg, E Coon, P Cortelli, ...
Movement Disorders 34 (7), 975-984, 2019
Prevalence and associated factors of sarcopenia and frailty in ParkinsonĘs disease: a cross-sectional study
M Peball, P Mahlknecht, M Werkmann, K Marini, F Murr, H Herzmann, ...
Gerontology 65 (3), 216-228, 2019
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
B Laurens, R Constantinescu, R Freeman, A Gerhard, K Jellinger, ...
Neurobiology of disease 80, 29-41, 2015
Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
DB Archer, JT Bricker, WT Chu, RG Burciu, JL McCracken, S Lai, ...
The Lancet Digital Health 1 (5), e222-e231, 2019
Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
M Peball, F Krismer, HG Knaus, A Djamshidian, M Werkmann, F Carbone, ...
Annals of neurology 88 (4), 712-722, 2020
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease
P Mahlknecht, R Pechlaner, S Boesveldt, D Volc, B Pinter, E Reiter, ...
Movement Disorders 31 (9), 1408-1413, 2016
The system can't perform the operation now. Try again later.
Articles 1–20